SAFE Words, Dangerous Bills & One Angry Mike Tyson: The Highs, the Lows, and the Bills That Just Won’t Pass

Tyson’s swinging, Kentucky’s growing, SCOTUS is ghosting, SAFE’s stalling, and hemp’s on the chopping block.

---

The Pressure's Rising. The Clock Is Ticking. The Industry Can't Wait.

This week, federal cannabis reform finds itself both center stage and stuck in limbo. Mike Tyson’s high-profile call to action may have reignited public debate, but in Washington, urgency is missing in action. SAFE Banking reform? Delayed until fall. The Supreme Court? Not your shortcut to Schedule III.

Meanwhile, Congress inches forward on veterans’ access to cannabis and psychedelics, while Kentucky quietly lays the groundwork for its medical market. But it's the hemp industry that faces the most immediate threat—thanks to a House-approved ban that could gut Delta-8, CBD, and every compliant product in between.

For operators, financiers, and policy strategists, the signal is clear: there’s no cavalry coming from the courts. All eyes must shift to the Senate, the statehouses, and the budgetary battles unfolding behind closed doors. The opportunity is real—but so is the risk.

---

Tyson Throws a Hook at Federal Cannabis Law

Boxing icon Mike Tyson is stepping into a new ring—federal cannabis reform. In a Fox News appearance, Tyson called on Trump to reclassify marijuana, pardon nonviolent cannabis inmates, and open banking channels for the legal industry. He slammed the status quo: “It’s insane weed is still lumped with heroin.”

For business leaders, it’s more than a celebrity soundbite—it’s a push that brings cannabis rescheduling, 280E reform, and banking access back into national headlines. If Trump bites, the industry could see a seismic shift before 2026.

🗣️ Takeaway: “Tyson might have retired from boxing, but he’s still landing policy punches.”

---

Supreme Court Not Interested in Cannabis Industry Lawsuit

The cannabis sector’s high-profile lawsuit, Canna Provisions v. Garland, just got its reality check. Former DOJ official James Mann says the case has “zero chance” of being reviewed by the Supreme Court—despite a clean lower court win.